Breaking News Instant updates and real-time market news.

RESN

Resonant

$2.41 /

-0.055 (-2.23%)

08:38
10/07/20
10/07
08:38
10/07/20
08:38

Resonant CEO says guidance 'remains unchanged' for 2H20

"The acceleration in our business is becoming apparent in the third quarter of 2020, as we delivered against all of our key metrics, including an increase in units shipped by customers, new library designs delivered to customers, robust revenue growth and a reduction in cash consumption," said George Holmes, Chairman and CEO of Resonant. "Perhaps most important is the achievement of the second 5G XBAR filter milestone with our strategic partner, who is the world's largest RF filter manufacturer. The achievement of this significant milestone confirms our technology meets the necessary metrics to move towards mass production, while also providing an influx of pre-paid royalties which will be recognized over the remainder of the contract. Taken together, Resonant currently stands in a stronger position than ever to capitalize on the multi-billion dollar 5G market. While large pre-payments, like those received in the third quarter of this year, greatly enhance both the recognition of revenues in the future as well as our cash position, they also result in non-linear revenue amounts from quarter to quarter, which we will see in the fourth quarter. Our guidance for the second half of 2020 remains unchanged."

  • 17

    Nov

  • 07

    Feb

RESN Resonant
$2.41 /

-0.055 (-2.23%)

02/28/20
Fly Intel: Top five analyst initiations
02/28/20 Stifel
Resonant initiated with a Buy at Stifel

TODAY'S FREE FLY STORIES

Hot Stocks
Netflix says past year 'testament' to company's approach » 16:10
01/19/21
01/19
16:10
01/19/21
16:10
NFLX

Netflix

$500.80 /

+2.85 (+0.57%)

, DIS

Disney

$172.39 /

+0.91 (+0.53%)

, DISCA

Discovery

$36.14 /

-0.62 (-1.69%)

, VIAC

ViacomCBS

$43.77 /

-1.52 (-3.36%)

, AAPL

Apple

$127.87 /

+0.8 (+0.63%)

, T

AT&T

$29.02 /

-0.16 (-0.55%)

, CMCSA

Comcast

$48.85 /

+0.17 (+0.35%)

Netflix said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$500.80 /

+2.85 (+0.57%)

DIS Disney
$172.39 /

+0.91 (+0.53%)

DISCA Discovery
$36.14 /

-0.62 (-1.69%)

VIAC ViacomCBS
$43.77 /

-1.52 (-3.36%)

AAPL Apple
$127.87 /

+0.8 (+0.63%)

T AT&T
$29.02 /

-0.16 (-0.55%)

CMCSA Comcast
$48.85 /

+0.17 (+0.35%)

NFLX Netflix
$500.80 /

+2.85 (+0.57%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
DIS Disney
$172.39 /

+0.91 (+0.53%)

01/15/21 MoffettNathanson
Disney price target raised to $180 from $160 at MoffettNathanson
01/14/21 Citi
Disney price target raised to $205 from $175 at Citi
01/14/21 Citi
Netflix price target raised to $580 from $450 at Citi
01/13/21 KeyBanc
New 'Star Wars' game 'certainly a boost' for Ubisoft pipeline, says KeyBanc
DISCA Discovery
$36.14 /

-0.62 (-1.69%)

09:53 Today
Fly Intel: Top five analyst downgrades
07:51 Today Credit Suisse
Discovery price target raised to $41 from $33 at Credit Suisse
07:22 Today Evercore ISI
Discovery added to 'Tactical Outperform list' at Evercore ISI
06:33 Today Barclays
Discovery downgraded to Underweight from Equal Weight at Barclays
VIAC ViacomCBS
$43.77 /

-1.52 (-3.36%)

09:53 Today
Fly Intel: Top five analyst downgrades
06:30 Today Barclays
ViacomCBS downgraded to Underweight from Overweight at Barclays
01/15/21 MoffettNathanson
ViacomCBS price target raised to $50 from $26 at MoffettNathanson
01/12/21 Wells Fargo
ViacomCBS price target raised to $43 from $30 at Wells Fargo
AAPL Apple
$127.87 /

+0.8 (+0.63%)

14:54 Today Craig-Hallum
Lumentum acquisition of Coherent 'a good fit in many ways,' says Craig-Hallum
05:02 Today BMO Capital
Facebook upgraded to Outperform from Market Perform at BMO Capital
01/15/21 Goldman Sachs
Goldman Sachs raises short-term forecasts for Apple, maintains Sell rating
01/15/21 Loop Capital
Apple price target raised to $155 from $131 at Loop Capital
T AT&T
$29.02 /

-0.16 (-0.55%)

01/04/21
Fly Intel: Top five analyst upgrades
01/04/21 Raymond James
AT&T upgraded to Outperform from Market Perform at Raymond James
01/04/21 Raymond James
AT&T upgraded to Outperform from Market Perform at Raymond James
12/24/20 Raymond James
AT&T estimates lowered ahead of Q4 report at Raymond James
CMCSA Comcast
$48.85 /

+0.17 (+0.35%)

06:41 Today Barclays
Comcast price target raised to $53 from $48 at Barclays
01/14/21 Macquarie
Comcast price target raised to $58 from $53 at Macquarie
12/16/20 Morgan Stanley
Morgan Stanley names Comcast a top pick, raises price target to $62
11/25/20 TD Securities
Comcast downgraded to Hold after recent rally at TD Securities
NFLX Netflix
$500.80 /

+2.85 (+0.57%)

DIS Disney
$172.39 /

+0.91 (+0.53%)

DISCA Discovery
$36.14 /

-0.62 (-1.69%)

VIAC ViacomCBS
$43.77 /

-1.52 (-3.36%)

AAPL Apple
$127.87 /

+0.8 (+0.63%)

T AT&T
$29.02 /

-0.16 (-0.55%)

CMCSA Comcast
$48.85 /

+0.17 (+0.35%)

NFLX Netflix
$500.80 /

+2.85 (+0.57%)

DIS Disney
$172.39 /

+0.91 (+0.53%)

DISCA Discovery
$36.14 /

-0.62 (-1.69%)

VIAC ViacomCBS
$43.77 /

-1.52 (-3.36%)

AAPL Apple
$127.87 /

+0.8 (+0.63%)

T AT&T
$29.02 /

-0.16 (-0.55%)

CMCSA Comcast
$48.85 /

+0.17 (+0.35%)

NFLX Netflix
$500.80 /

+2.85 (+0.57%)

DIS Disney
$172.39 /

+0.91 (+0.53%)

DISCA Discovery
$36.14 /

-0.62 (-1.69%)

VIAC ViacomCBS
$43.77 /

-1.52 (-3.36%)

AAPL Apple
$127.87 /

+0.8 (+0.63%)

T AT&T
$29.02 /

-0.16 (-0.55%)

CMCSA Comcast
$48.85 /

+0.17 (+0.35%)

NFLX Netflix
$500.80 /

+2.85 (+0.57%)

DIS Disney
$172.39 /

+0.91 (+0.53%)

DISCA Discovery
$36.14 /

-0.62 (-1.69%)

VIAC ViacomCBS
$43.77 /

-1.52 (-3.36%)

AAPL Apple
$127.87 /

+0.8 (+0.63%)

T AT&T
$29.02 /

-0.16 (-0.55%)

CMCSA Comcast
$48.85 /

+0.17 (+0.35%)

Hot Stocks
eXp World Holdings announces 2-for-1 stock split in form of a dividend » 16:10
01/19/21
01/19
16:10
01/19/21
16:10
EXPI

eXp World Holdings

$79.62 /

+1.67 (+2.14%)

eXp World Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EXPI eXp World Holdings
$79.62 /

+1.67 (+2.14%)

EXPI eXp World Holdings
$79.62 /

+1.67 (+2.14%)

11/10/20 DA Davidson
eXp World Holdings price target raised to $53 from $28 at DA Davidson
04/20/20 Stephens
Stephens ups CoreLogic, downgrades two others in real estate services shake-up
EXPI eXp World Holdings
$79.62 /

+1.67 (+2.14%)

EXPI eXp World Holdings
$79.62 /

+1.67 (+2.14%)

EXPI eXp World Holdings
$79.62 /

+1.67 (+2.14%)

EXPI eXp World Holdings
$79.62 /

+1.67 (+2.14%)

Syndicate
Lithium Americas files to sell common stock, no amount given » 16:09
01/19/21
01/19
16:09
01/19/21
16:09
LAC

Lithium Americas

$26.69 /

+6.16 (+30.00%)

Canaccord Genuity is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LAC Lithium Americas
$26.69 /

+6.16 (+30.00%)

LAC Lithium Americas
$26.69 /

+6.16 (+30.00%)

01/06/21 Canaccord
Lithium Americas price target raised to C$20 from C$11.50 at Canaccord
12/23/20 Stifel
Stifel starts Lithium Americas with Buy, sees 'attractive upside'
12/22/20 Stifel
Lithium Americas initiated with a Buy at Stifel
10/21/20 Roth Capital
Lithium Americas downgraded to Neutral from Buy at Roth Capital
LAC Lithium Americas
$26.69 /

+6.16 (+30.00%)

LAC Lithium Americas
$26.69 /

+6.16 (+30.00%)

LAC Lithium Americas
$26.69 /

+6.16 (+30.00%)

Hot Stocks
J.B. Hunt jumps 3% to $153.00 after Q4 earnings beat  16:09
01/19/21
01/19
16:09
01/19/21
16:09
JBHT

J.B. Hunt

$148.51 /

-3.145 (-2.07%)

 
ShowHide Related Items >><<
JBHT J.B. Hunt
$148.51 /

-3.145 (-2.07%)

JBHT J.B. Hunt
$148.51 /

-3.145 (-2.07%)

06:10 Today Credit Suisse
J.B. Hunt upgraded to Outperform from Neutral at Credit Suisse
01/06/21 Citi
J.B. Hunt upgraded to Buy from Neutral at Citi
01/05/21 Stephens
J.B. Hunt price target raised to $167 from $155 at Stephens
11/30/20 Deutsche Bank
J.B. Hunt price target raised to $139 from $132 at Deutsche Bank
JBHT J.B. Hunt
$148.51 /

-3.145 (-2.07%)

JBHT J.B. Hunt
$148.51 /

-3.145 (-2.07%)

JBHT J.B. Hunt
$148.51 /

-3.145 (-2.07%)

Hot Stocks
Histogen reports clinical hold on Phase 1/2 Trial of HST-003 for knee cartilage » 16:09
01/19/21
01/19
16:09
01/19/21
16:09
HSTO

Histogen

$1.17 /

+0.16 (+15.84%)

Histogen announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HSTO Histogen
$1.17 /

+0.16 (+15.84%)

  • 31
    Dec
HSTO Histogen
$1.17 /

+0.16 (+15.84%)

HSTO Histogen
$1.17 /

+0.16 (+15.84%)

General news
Treasury International Capital Net Long-Term Securities Transactions data reported » 16:08
01/19/21
01/19
16:08
01/19/21
16:08

November Treasury…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
J.B. Hunt says Q4 revenue growth driven by ICS and Truck segments » 16:08
01/19/21
01/19
16:08
01/19/21
16:08
JBHT

J.B. Hunt

$148.32 /

-3.33 (-2.20%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JBHT J.B. Hunt
$148.32 /

-3.33 (-2.20%)

JBHT J.B. Hunt
$148.32 /

-3.33 (-2.20%)

06:10 Today Credit Suisse
J.B. Hunt upgraded to Outperform from Neutral at Credit Suisse
01/06/21 Citi
J.B. Hunt upgraded to Buy from Neutral at Citi
01/05/21 Stephens
J.B. Hunt price target raised to $167 from $155 at Stephens
11/30/20 Deutsche Bank
J.B. Hunt price target raised to $139 from $132 at Deutsche Bank
JBHT J.B. Hunt
$148.32 /

-3.33 (-2.20%)

JBHT J.B. Hunt
$148.32 /

-3.33 (-2.20%)

JBHT J.B. Hunt
$148.32 /

-3.33 (-2.20%)

Hot Stocks
Inspire appoints Bryan Phillips as chief compliance officer, general counsel » 16:08
01/19/21
01/19
16:08
01/19/21
16:08
INSP

Inspire Medical

$224.07 /

+14.13 (+6.73%)

, CERE

Cerevel Therapeutics

$14.51 /

+0.095 (+0.66%)

Inspire Medical (INSP)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INSP Inspire Medical
$224.07 /

+14.13 (+6.73%)

CERE Cerevel Therapeutics
$14.51 /

+0.095 (+0.66%)

INSP Inspire Medical
$224.07 /

+14.13 (+6.73%)

01/07/21 Lake Street
Inspire Medical price target raised to $215 from $150 at Lake Street
01/04/21 BofA
Inspire Medical downgraded to Neutral from Buy at BofA
12/15/20 Goldman Sachs
Inspire Medical downgraded to Neutral from Buy at Goldman Sachs
12/03/20 Piper Sandler
Inspire Medical price target raised to $210 from $147 at Piper Sandler
CERE Cerevel Therapeutics
$14.51 /

+0.095 (+0.66%)

12/10/20 Goldman Sachs
Cerevel Therapeutics initiated with a Buy at Goldman Sachs
11/23/20 Jefferies
Cerevel Therapeutics initiated with a Buy at Jefferies
11/09/20
Fly Intel: Top five analyst initiations
11/09/20 Stifel
Cerevel Therapeutics initiated with a Buy at Stifel
INSP Inspire Medical
$224.07 /

+14.13 (+6.73%)

  • 14
    Apr
INSP Inspire Medical
$224.07 /

+14.13 (+6.73%)

CERE Cerevel Therapeutics
$14.51 /

+0.095 (+0.66%)

Initiation
Datadog initiated with a Buy at Truist » 16:08
01/19/21
01/19
16:08
01/19/21
16:08
DDOG

Datadog

$98.92 /

-0.875 (-0.88%)

Truist analyst Joel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DDOG Datadog
$98.92 /

-0.875 (-0.88%)

DDOG Datadog
$98.92 /

-0.875 (-0.88%)

01/11/21 Jefferies
Datadog upgraded to Buy from Hold at Jefferies
12/17/20 Rosenblatt
Datadog initiated with Neutral, $97 price target at Rosenblatt
12/16/20 Rosenblatt
Datadog initiated with a Buy at Rosenblatt
11/23/20 KeyBanc
Datadog initiated with a Sector Weight at KeyBanc
DDOG Datadog
$98.92 /

-0.875 (-0.88%)

DDOG Datadog
$98.92 /

-0.875 (-0.88%)

DDOG Datadog
$98.92 /

-0.875 (-0.88%)

Hot Stocks
Nu Skin reports on environmental impact of its top products » 16:07
01/19/21
01/19
16:07
01/19/21
16:07
NUS

Nu Skin

$57.79 /

+2.16 (+3.88%)

Nu Skin reported it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NUS Nu Skin
$57.79 /

+2.16 (+3.88%)

11/05/20 Deutsche Bank
Nu Skin price target raised to $57 from $49 at Deutsche Bank
10/02/20 DA Davidson
Nu Skin price target raised to $68 from $61 at DA Davidson
10/02/20 BofA
Nu Skin upgraded to Neutral from Underperform at BofA
10/02/20 BofA
Nu Skin upgraded to Neutral from Underperform at BofA
NUS Nu Skin
$57.79 /

+2.16 (+3.88%)

NUS Nu Skin
$57.79 /

+2.16 (+3.88%)

Initiation
Checkpoint Therapeutics initiated with an Overweight at Cantor Fitzgerald » 16:07
01/19/21
01/19
16:07
01/19/21
16:07
CKPT

Checkpoint Therapeutics

$3.31 /

-0.045 (-1.34%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CKPT Checkpoint Therapeutics
$3.31 /

-0.045 (-1.34%)

CKPT Checkpoint Therapeutics
$3.31 /

-0.045 (-1.34%)

09/29/20 H.C. Wainwright
Checkpoint Therapeutics price target raised to $17 from $15 at H.C. Wainwright
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
04/13/20 B. Riley FBR
AstraZeneca study halt has positive read-through to Fortress, says B. Riley FBR
CKPT Checkpoint Therapeutics
$3.31 /

-0.045 (-1.34%)

  • 18
    Sep
CKPT Checkpoint Therapeutics
$3.31 /

-0.045 (-1.34%)

Earnings
J.B. Hunt reports Q4 EPS $1.44, consensus $1.30 » 16:07
01/19/21
01/19
16:07
01/19/21
16:07
JBHT

J.B. Hunt

$148.42 /

-3.23 (-2.13%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JBHT J.B. Hunt
$148.42 /

-3.23 (-2.13%)

JBHT J.B. Hunt
$148.42 /

-3.23 (-2.13%)

06:10 Today Credit Suisse
J.B. Hunt upgraded to Outperform from Neutral at Credit Suisse
01/06/21 Citi
J.B. Hunt upgraded to Buy from Neutral at Citi
01/05/21 Stephens
J.B. Hunt price target raised to $167 from $155 at Stephens
11/30/20 Deutsche Bank
J.B. Hunt price target raised to $139 from $132 at Deutsche Bank
JBHT J.B. Hunt
$148.42 /

-3.23 (-2.13%)

JBHT J.B. Hunt
$148.42 /

-3.23 (-2.13%)

JBHT J.B. Hunt
$148.42 /

-3.23 (-2.13%)

Hot Stocks
Netflix says 'very close to being sustainably FCF positive' » 16:07
01/19/21
01/19
16:07
01/19/21
16:07
NFLX

Netflix

$500.52 /

+2.57 (+0.52%)

Netflix said: "We…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$500.52 /

+2.57 (+0.52%)

NFLX Netflix
$500.52 /

+2.57 (+0.52%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$500.52 /

+2.57 (+0.52%)

NFLX Netflix
$500.52 /

+2.57 (+0.52%)

NFLX Netflix
$500.52 /

+2.57 (+0.52%)

NFLX Netflix
$500.52 /

+2.57 (+0.52%)

Hot Stocks
PACCAR, Aurora form strategic partnership over autonomous trucks » 16:07
01/19/21
01/19
16:07
01/19/21
16:07
PCAR

Paccar

$89.22 /

+1 (+1.13%)

PACCAR and Aurora have…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PCAR Paccar
$89.22 /

+1 (+1.13%)

PCAR Paccar
$89.22 /

+1 (+1.13%)

01/13/21 Deutsche Bank
Paccar named 'Catalyst Call: Buy Idea' at Deutsche Bank
01/07/21 Wolfe Research
Paccar downgraded to Underperform from Peer Perform at Wolfe Research
12/28/20 Barclays
Rising steel prices possible headwind for machinery companies, says Barclays
12/15/20 Morgan Stanley
Paccar upgraded to Equal Weight on expected Class 8 recovery at Morgan Stanley
PCAR Paccar
$89.22 /

+1 (+1.13%)

PCAR Paccar
$89.22 /

+1 (+1.13%)

Syndicate
AcelRx announces offering of common stock, no amount given » 16:06
01/19/21
01/19
16:06
01/19/21
16:06
ACRX

AcelRx

$2.36 /

+0.29 (+14.01%)

Cantor Fitzgerald &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACRX AcelRx
$2.36 /

+0.29 (+14.01%)

ACRX AcelRx
$2.36 /

+0.29 (+14.01%)

07/24/20 H.C. Wainwright
AcelRx deal with Zimmer Biomet a 'win-win,' says H.C. Wainwright
07/20/20
Fly Intel: Top five analyst downgrades
07/20/20 Credit Suisse
AcelRx downgraded to Underperform on 'mounting challenges' at Credit Suisse
07/20/20 Credit Suisse
AcelRx downgraded to Underperform from Neutral at Credit Suisse
ACRX AcelRx
$2.36 /

+0.29 (+14.01%)

ACRX AcelRx
$2.36 /

+0.29 (+14.01%)

ACRX AcelRx
$2.36 /

+0.29 (+14.01%)

Syndicate
Editas Medicine files to sell 3.5M shares common stock » 16:06
01/19/21
01/19
16:06
01/19/21
16:06
EDIT

Editas Medicine

$71.66 /

-4.42 (-5.81%)

J.P. Morgan and Morgan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDIT Editas Medicine
$71.66 /

-4.42 (-5.81%)

EDIT Editas Medicine
$71.66 /

-4.42 (-5.81%)

07:41 Today Morgan Stanley
Editas Medicine downgraded to Underweight from Equal Weight at Morgan Stanley
01/13/21 Wells Fargo
Editas Medicine price target raised to $86 from $69 at Wells Fargo
01/08/21 Raymond James
Editas downgraded to Market Perform at Raymond James (Thursday morning)
01/07/21 Raymond James
Editas Medicine downgraded to Market Perform from Outperform at Raymond James
EDIT Editas Medicine
$71.66 /

-4.42 (-5.81%)

  • 24
    Jun
EDIT Editas Medicine
$71.66 /

-4.42 (-5.81%)

EDIT Editas Medicine
$71.66 /

-4.42 (-5.81%)

EDIT Editas Medicine
$71.66 /

-4.42 (-5.81%)

Hot Stocks
Netflix now targets 20% operating margin in FY21 » 16:06
01/19/21
01/19
16:06
01/19/21
16:06
NFLX

Netflix

$500.56 /

+2.61 (+0.52%)

Netflix said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$500.56 /

+2.61 (+0.52%)

NFLX Netflix
$500.56 /

+2.61 (+0.52%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$500.56 /

+2.61 (+0.52%)

NFLX Netflix
$500.56 /

+2.61 (+0.52%)

NFLX Netflix
$500.56 /

+2.61 (+0.52%)

NFLX Netflix
$500.56 /

+2.61 (+0.52%)

Hot Stocks
RF Industries promotes Peter Yin to CFO » 16:05
01/19/21
01/19
16:05
01/19/21
16:05
RFIL

RF Industries

$5.11 /

-0.01 (-0.20%)

RF Industries announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RFIL RF Industries
$5.11 /

-0.01 (-0.20%)

12/18/20 B. Riley Securities
RF Industries price target raised to $6.75 from $6.25 at B. Riley Securities
03/03/20
LD Micro to hold a virtual conference
01/29/20 B. Riley FBR
B. Riley FBR starts 'under the radar' RF Industries with Buy rating
01/29/20 B. Riley FBR
RF Industries initiated with a Buy at B. Riley FBR
Recommendations
Fate Therapeutics price target raised to $135 from $70 at Oppenheimer » 16:05
01/19/21
01/19
16:05
01/19/21
16:05
FATE

Fate Therapeutics

$113.88 /

+0.38 (+0.33%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FATE Fate Therapeutics
$113.88 /

+0.38 (+0.33%)

FATE Fate Therapeutics
$113.88 /

+0.38 (+0.33%)

01/15/21 Barclays
Fate Therapeutics price target raised to $130 from $110 at Barclays
12/21/20 Stifel
Fate Therapeutics price target raised to $118 from $79 at Stifel
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
12/17/20 Barclays
Fate Therapeutics price target raised to $110 from $80 at Barclays
FATE Fate Therapeutics
$113.88 /

+0.38 (+0.33%)

  • 06
    Jan
  • 09
    Jun
FATE Fate Therapeutics
$113.88 /

+0.38 (+0.33%)

Hot Stocks
BridgeBio and Eidos' stockholders approve acquisition » 16:05
01/19/21
01/19
16:05
01/19/21
16:05
BBIO

BridgeBio

$69.23 /

+0.62 (+0.90%)

, EIDX

Eidos Therapeutics

$127.90 /

+1.37 (+1.08%)

BridgeBio Pharma (BBIO)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBIO BridgeBio
$69.23 /

+0.62 (+0.90%)

EIDX Eidos Therapeutics
$127.90 /

+1.37 (+1.08%)

BBIO BridgeBio
$69.23 /

+0.62 (+0.90%)

01/11/21 H.C. Wainwright
BridgeBio price target raised to $87 from $64 at H.C. Wainwright
12/30/20 Citi
Eidos Therapeutics price target raised to $129 from $73.26 at Citi
12/14/20 BTIG
BridgeBio price target raised to $91 from $49 at BTIG
12/10/20 H.C. Wainwright
BridgeBio price target raised to $64 from $53 at H.C. Wainwright
EIDX Eidos Therapeutics
$127.90 /

+1.37 (+1.08%)

12/30/20 Citi
Eidos Therapeutics price target raised to $129 from $73.26 at Citi
11/18/20 BTIG
Eidos Therapeutics downgraded to Neutral from Buy at BTIG
10/12/20 H.C. Wainwright
BridgeBio price target raised to $53 from $50 at H.C. Wainwright
10/07/20
Fly Intel: Top five analyst downgrades
BBIO BridgeBio
$69.23 /

+0.62 (+0.90%)

EIDX Eidos Therapeutics
$127.90 /

+1.37 (+1.08%)

  • 29
    May
BBIO BridgeBio
$69.23 /

+0.62 (+0.90%)

EIDX Eidos Therapeutics
$127.90 /

+1.37 (+1.08%)

BBIO BridgeBio
$69.23 /

+0.62 (+0.90%)

EIDX Eidos Therapeutics
$127.90 /

+1.37 (+1.08%)

Earnings
Perion Network sees Q4 EPS 35c-36, consensus 23c » 16:05
01/19/21
01/19
16:05
01/19/21
16:05
PERI

Perion Network

$13.92 /

+0.91 (+6.99%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PERI Perion Network
$13.92 /

+0.91 (+6.99%)

PERI Perion Network
$13.92 /

+0.91 (+6.99%)

01/04/21 Lake Street
Perion Network price target raised to $18 from $12 at Lake Street
12/31/20 Sidoti
Perion Network price target raised to $14 from $12 at Sidoti
11/19/20
Fly Intel: Top five analyst initiations
11/19/20 Roth Capital
Perion Network initiated with a Buy at Roth Capital
PERI Perion Network
$13.92 /

+0.91 (+6.99%)

PERI Perion Network
$13.92 /

+0.91 (+6.99%)

Hot Stocks
Netflix up 7% after Q4 results, Q1 guidance » 16:04
01/19/21
01/19
16:04
01/19/21
16:04
NFLX

Netflix

$500.78 /

+2.83 (+0.57%)

Shares of Netflix are up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$500.78 /

+2.83 (+0.57%)

NFLX Netflix
$500.78 /

+2.83 (+0.57%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$500.78 /

+2.83 (+0.57%)

NFLX Netflix
$500.78 /

+2.83 (+0.57%)

NFLX Netflix
$500.78 /

+2.83 (+0.57%)

NFLX Netflix
$500.78 /

+2.83 (+0.57%)

Hot Stocks
Netflix sees Q1 global streaming paid net additions of 6.0M » 16:03
01/19/21
01/19
16:03
01/19/21
16:03
NFLX

Netflix

$501.02 /

+3.07 (+0.62%)

Netflix said in its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$501.02 /

+3.07 (+0.62%)

NFLX Netflix
$501.02 /

+3.07 (+0.62%)

10:13 Today JPMorgan
JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
01/15/21 Citi
Citi cuts Spotify to Sell with no benefit seen on podcast investments
01/15/21 Piper Sandler
Netflix search index suggests in-line Q4 subscriber results, says Piper Sandler
01/14/21 Barclays
Netflix could add 90M Asia-Pacific subs in five years, says Barclays
NFLX Netflix
$501.02 /

+3.07 (+0.62%)

NFLX Netflix
$501.02 /

+3.07 (+0.62%)

NFLX Netflix
$501.02 /

+3.07 (+0.62%)

NFLX Netflix
$501.02 /

+3.07 (+0.62%)

Hot Stocks
Echo Global appoints Brian Parchem as Chief Information Officer » 16:03
01/19/21
01/19
16:03
01/19/21
16:03
ECHO

Echo Global

$27.34 /

+0.24 (+0.89%)

Echo Global Logistics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ECHO Echo Global
$27.34 /

+0.24 (+0.89%)

ECHO Echo Global
$27.34 /

+0.24 (+0.89%)

01/06/21 Barrington
Imax and Sirius XM among Barrington's best ideas for 2021
11/06/20 Barrington
Echo Global price target raised to $36 from $30 at Barrington
07/24/20 Barrington
Echo Global price target raised to $30 from $22 at Barrington
07/17/20 SunTrust
SunTrust raises price targets in select Trucking/Logistics names
ECHO Echo Global
$27.34 /

+0.24 (+0.89%)

Earnings
Nicolet Bankshares reports Q4 EPS $1.74, consensus $1.49  16:03
01/19/21
01/19
16:03
01/19/21
16:03
NCBS

Nicolet Bankshares

$71.90 /

-0.39 (-0.54%)

 
ShowHide Related Items >><<
NCBS Nicolet Bankshares
$71.90 /

-0.39 (-0.54%)

NCBS Nicolet Bankshares
$71.90 /

-0.39 (-0.54%)

10/23/20 Maxim
Nicolet Bankshares price target raised to $77 from $70 at Maxim
10/09/20 Stephens
Stephens starts Nicolet Bankshares at Equal Weight, citing valuation
10/09/20 Stephens
Nicolet Bankshares initiated with an Equal Weight at Stephens
NCBS Nicolet Bankshares
$71.90 /

-0.39 (-0.54%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.